Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Nephritis (LN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05495893
What this trial is testing

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

Who this might be right for
Mycophenolate MofetilCyclophosphamideLupus Nephritis
Second Xiangya Hospital of Central South University 224
Not applicableUnknownNCT04894695
What this trial is testing

Urine Exosomes to Identify Biomarkers for LN

Who this might be right for
Lupus Nephritis
RenJi Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT07363460
What this trial is testing

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Who this might be right for
Lupus Nephritis (LN)
Haisco Pharmaceutical Group Co., Ltd. 105
Not applicableLooking for participantsNCT06682507
What this trial is testing

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

Who this might be right for
Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableNot Yet RecruitingNCT07719322
What this trial is testing

Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)
Assiut University 156
Early research (Phase 1)WithdrawnNCT06377228
What this trial is testing

TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Who this might be right for
Refractory Lupus NephritisRefractory Systemic Sclerosis
Takeda
Large-scale testing (Phase 3)Active Not RecruitingNCT05126277
What this trial is testing

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 452
Testing effectiveness (Phase 2)Ended earlyNCT05540665
What this trial is testing

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Amgen 19
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Testing effectiveness (Phase 2)Looking for participantsNCT06839976
What this trial is testing

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Who this might be right for
SLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more
Children's Hospital of Philadelphia 24
Not applicableStudy completedNCT04645589
What this trial is testing

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 69
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Not applicableStudy completedNCT03664908
What this trial is testing

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

Who this might be right for
Lupus Nephritis
CHU de Reims 100
Post-approval studies (Phase 4)Looking for participantsNCT07700940
What this trial is testing

The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population

Who this might be right for
Lupus Nephritis (LN)
Ahmed Yehia Ismail 66
Post-approval studies (Phase 4)Looking for participantsNCT07719140
What this trial is testing

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Who this might be right for
Childhood-onset Systemic Lupus ErythematosusLupus Nephritis (LN)
Peking Union Medical College Hospital 198
Not applicableUnknownNCT05585671
What this trial is testing

Belimumab In Prevention of LN

Who this might be right for
Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
RenJi Hospital 48
Next Page